DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy
NCT05905822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2025-11-18
Summary
This study will involve donating a salivary sample and a faecal (stool) sample. These will be analysed in the laboratory to determine the forms of the APOE gene you are carrying (your APOE genotype) and the response of the bacteria in your colon to reactive compounds extracted from edible plants (dietary bioactives).
Conditions
- Alzheimer Disease
Sponsors & Collaborators
-
Quadram Institute Bioscience
collaborator OTHER -
University of East Anglia
lead OTHER
Principal Investigators
-
David Vauzour, PhD · University of East Anglia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-19
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
NCT00777361 ·Status: TERMINATED ·Phase: PHASE1
-
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
NCT03486938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Clinical Trial of AGB101 for Mild Cognitive Impairment
NCT05986721 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1
-
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
NCT04804618 ·Status: RECRUITING
-
Correlation of P-glycoprotein Polymorphisms With Microbial Metabolites in Patients With Alzheimer's Disease on Medication
NCT05532644 ·Status: UNKNOWN
-
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
NCT05591027 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease
NCT05771428 ·Status: COMPLETED ·Phase: PHASE2
-
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
NCT02221622 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease
NCT06920212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Cytokines and Cognitive Decline in Alzheimer's Disease
NCT01351142 ·Status: COMPLETED ·Phase: NA
-
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment
NCT03780621 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease
NCT05578443 ·Status: RECRUITING ·Phase: PHASE2
-
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease
NCT02800395 ·Status: RECRUITING ·Phase: NA
-
AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)
NCT01211782 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00149175 ·Status: COMPLETED
-
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
NCT00722046 ·Status: COMPLETED ·Phase: PHASE2
-
Intervention of Intestinal Microorganism in Mild Cognitive Impairment
NCT03991195 ·Status: COMPLETED ·Phase: NA
-
Effects of Pomegranate Seed Oil and Mediterranean Diet on MCI
NCT04990362 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
NCT01538212 ·Status: COMPLETED
-
Effect of AQW051 in Patients With Memory Impairment
NCT00582855 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
NCT03112096 ·Status: COMPLETED ·Phase: PHASE1